Molly Henderson, CFO and CBO at Phathom Pharmaceuticals, Inc. (PHAT), sold 1,960 shares at $11.41 ($22K) on 2023-06-02, disclosed to the SEC on 2023-06-05.
Scheduled sale ($22k) by CFO and CBO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| PHAT | SELL | 2024-12-20 | $10K | — | Filing → |
| PHAT | SELL | 2024-07-17 | $51K | — | Filing → |
| PHAT | SELL | 2024-04-10 | $38K | — | Filing → |